Management of penile shortening after
Peyronie's disease surgery
Objective
To assess the value, in terms of increasing the length of
the penis, of 8 to 12-hour daily application of a penile extender device after
penile surgery for Peyronie's disease (PD). A secondary objective was to assess
the health related quality of life (HRQOL) outcome in patients using the Size
Genetics penis extender device.
Design and methods
30
men, ages 54-64 years (mean: 58), underwent penile surgery for PD. In eight
patients the surgical technique was incision of the fibrous plaque and grafting,
while the rest 22 underwent plication of the albuginea (Essed technique) 15 of
the 30 patients were treated with a Size Genetics penile extender daily over a
4-month period. Length and girth of the penis was measured before and after
surgery and after the use of the extender. HRQOL was also determined using the
SF-36 survey to compare both groups of patients.
Results
Sustained treatment for 4 months with the penile
stretching device provided an increase from 1 to 4 cms and an increase in girth
of 0,5 to 1,5 cm. Comparing the results of the SF-36 survey a significant
difference could be observed between both groups (p < 0.001). The use of the
device was generally well tolerated, only 2 patients had moderate penile pain.
No other complications were recorded.
Conclusion
Use of the penile extender device on an 8 to 12-hour
daily regimen is an effective and safe way to minimize loss of penile length in
patients operated for PD. Its use provides a significant improvement on HRQOL
outcomes compared to the control group.
11th World Congress of the International Society for
Sexual and Impotence Research. Oct 17th-21st, 2004. Buenos Aires, Argentina.
7th Congress of the European Society for Sexual Medicine.
December5-8, 2004. London, UK.
Moncada, I.; Jara, José; Martínez-Salamanca, J.I.; Cabello,
R.; Hernández, C. Urology Unit. Hospital Gregorio Marañón, Madrid. Spain.
Index of scientific studies
Ordering information